03.01.09
A new study published in Redox Report shows that Pycnogenol French maritime pine bark extract, from Natural Health Science, significantly lowered plasma levels of C-reactive protein (CRP) in osteoarthritis patients.
The study, a joint effort between Italy’s Chieti-Pescara University and the University of Munster, Germany, investigated a subset of 55 patients from a previous osteoarthritis trial of 156 patients who had significantly elevated CRP levels. Treatment consisted of two tablets daily of either 50 mg Pycnogenol or placebo.
Blood specimens were drawn at baseline and again after the three-month treatment. Results showed that Pycnogenol significantly lowered CRP from the average 3.9 mg/L at baseline to 1.1 mg/L, reflecting essentially healthy levels. In the placebo group, a marginal lowered CRP level was detected. Other blood parameters indicative of acute inflammation likewise decreased with Pycnogenol, such as fibrinogen (lowered 37%) and reactive oxygen species (lowered by 30%). For further information: www.pycnogenol.com
The study, a joint effort between Italy’s Chieti-Pescara University and the University of Munster, Germany, investigated a subset of 55 patients from a previous osteoarthritis trial of 156 patients who had significantly elevated CRP levels. Treatment consisted of two tablets daily of either 50 mg Pycnogenol or placebo.
Blood specimens were drawn at baseline and again after the three-month treatment. Results showed that Pycnogenol significantly lowered CRP from the average 3.9 mg/L at baseline to 1.1 mg/L, reflecting essentially healthy levels. In the placebo group, a marginal lowered CRP level was detected. Other blood parameters indicative of acute inflammation likewise decreased with Pycnogenol, such as fibrinogen (lowered 37%) and reactive oxygen species (lowered by 30%). For further information: www.pycnogenol.com